Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

Healthcare Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Medipharm Labs Corp
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(264)
•••
Post by alleyesonmeon Jan 08, 2024 3:04pm
177 Views
Post# 35816188

Mr Strachan on X..

Mr Strachan on X..S1i...wow.."hurry up FDA" agree this says it all....global pharma partner expecting FDA approval...or clinical trial approval...explosive comments...he probably shouldn't of said anything..nevertheless, patiently wait we will...meanwhile dronabinol generic ready for Germany..ANVISA approval/shipments expected this quarter, possibly a new pharmaceutical..meanwhile DEA rescheduling announcement imminent..Canadian cannabis review, final report due for House of Commons/senate by March.....3m additional annualized  savings commenced Q3....Y/E,Q4 out March including sales without shelter royalties, higher margin German flower sales, and new high demand vapes, distillates and flower for the tighter Australian market to name a few...dang. 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities